Skip to main content

Table 2 General characteristics of subjects in ABM and control group

From: LRP5-/6 gene polymorphisms and its association with risk of abnormal bone mass in postmenopausal women

Variables

Control group

ABM group

P-value

Age (years)

67.78 (65.97–69.59)

67.88 (65.94–69.82)

0.953

Menopausal years

17.00 (11.50–22.50)

21.00 (18.00–24.00)

0.03*

WHR

0.90 (0.86–0.92)

0.90 (0.85–0.93)

0.22

BMI (kg/m2)

26.10 (23.49–28.95)

25.33 (23.00–27.47)

0.70

Ca (mmol/L)

2.26 (2.21–2.32)

2.26 (2.21–2.32)

0.96

P (mmol/L)

1.10 (1.03–1.14)

1.09 (0.99–1.16)

0.87

ALP (U/L)

75.00 (62.00–87.00)

75.00 (61.00–91.00)

0.97

BMD (L1–4) (g/m2)

1.16 (1.10–1.29)

0.92 (0.82–0.97)

0.00**

BMD (FN) (g/m2)

0.89 (0.80–0.94)

0.73 (0.65–0.81)

0.00**

  1. ABM Abnormal bone mass, WHR Waist-to-hip ratio, BMI Body mass index, ALP Alkaline phosphatase, BMD Bone mineral density
  2. Data were presented as means ± SD for median (interquartile ranges) for continuous variables. Compared with the control group
  3. Italicized value is statistically significant, *P < 0.05, **P < 0.01 indicates statistical significance